These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6134065)
1. HLA-DRw6-matching and primary renal graft failure due to rejection. Schmidt P; Balcke P; Zazgornik J; Hajek-Rosenmayr A; Mayr WR; Kretschmer G; Piza F Lancet; 1983 Jun; 1(8336):1277. PubMed ID: 6134065 [No Abstract] [Full Text] [Related]
2. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching. Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324 [No Abstract] [Full Text] [Related]
3. Poor kidney-graft survival in recipients with HLA-DRw6. Soulillou JP; Bignon JD N Engl J Med; 1983 Apr; 308(16):969-70. PubMed ID: 6339928 [No Abstract] [Full Text] [Related]
4. Influence of HLA-DRW6 in the recipient on occurrence of acute rejection of first renal allografts: beneficial influence of antithymocyte globulin as antirejection treatment. Hoitsma AJ; van Lier HJ; Reekers P; Koene RA Transplant Proc; 1984 Oct; 16(5):1156-8. PubMed ID: 6385363 [TBL] [Abstract][Full Text] [Related]
5. HLA-DRw6 and renal allograft rejection. Hendriks GF; Schreuder GM; Claas FH; D'Amaro J; Persijn GG; Cohen B; van Rood JJ Br Med J (Clin Res Ed); 1983 Jan; 286(6359):85-7. PubMed ID: 6401505 [TBL] [Abstract][Full Text] [Related]
6. HLA-DRW6 and treatment of acute rejection with antithymocyte globulin. Hoitsma AJ; Reekers P; van Lier HJ; van Rens JC; Koene RA Transplantation; 1984 Jul; 38(1):25-8. PubMed ID: 6377607 [TBL] [Abstract][Full Text] [Related]
7. The regulatory role of HLA-DRw6 in renal transplantation. Hendriks GF; Schreuder GM; D'Amaro J; van Rood JJ Tissue Antigens; 1986 Mar; 27(3):121-30. PubMed ID: 2940730 [No Abstract] [Full Text] [Related]
8. HLA-DRw6 locus in kidney transplantation. Lancet; 1983 Aug; 2(8346):402. PubMed ID: 6135899 [No Abstract] [Full Text] [Related]
9. DRw6 antigen and severe non-immunological complications. Hoyer J; Vosberg A Neth J Med; 1985; 28(6):259-61. PubMed ID: 3892327 [No Abstract] [Full Text] [Related]
11. The influence of HLA-DRw6 on donor-recipient selection in kidney transplantation. Hendriks GF; D'Amaro J; Persijn GG; Schreuder GM; Cohen B; Van Rood JJ Neth J Med; 1985; 28(6):235-8. PubMed ID: 3892323 [No Abstract] [Full Text] [Related]
12. HLA-DRW6 and autoantibodies in recipients of first kidney grafts. Reekers P; Raaben W; van der Beucken M; Kunst V; Hoitsma A; Koene R Transplant Proc; 1984 Oct; 16(5):1159-61. PubMed ID: 6385364 [No Abstract] [Full Text] [Related]
14. Excellent outcome after transplantation of renal allografts from HLA-DRw6-positive donors even in HLA-DR mismatches. Hendriks GF; D'Amaro J; Persijn GG; Schreuder GM; Lansbergen Q; Cohen B; van Rood JJ Lancet; 1983 Jul; 2(8343):187-9. PubMed ID: 6135028 [TBL] [Abstract][Full Text] [Related]
15. Reanalysis of the HLA-DRw6 complex. Schreuder GM; Parlevliet J; Termijtelen A; van Rood JJ Tissue Antigens; 1983 Jan; 21(1):62-74. PubMed ID: 6601316 [TBL] [Abstract][Full Text] [Related]
16. HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. Roenhorst HW; Tegzess AM; Beelen JM; Middeldorp JM; The TH Br Med J (Clin Res Ed); 1985 Sep; 291(6496):619-22. PubMed ID: 2992676 [TBL] [Abstract][Full Text] [Related]